Trajan Group Holdings Ltd

  • IPO date:
  • Sector: Healthcare
  • GIC Group: Health Care Equipment & Services
  • Industry: Medical Instruments & Supplies
  • Company website

Company description

Trajan Group Holdings Limited develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. It operates through Analytical Products and Life Science Solutions segments. The company offers analytical products, including syringes, GC columns and connections, rings, inlet liners, emitters, purifiers and filters, and tubing products; pathology products, such as NBF containers, adhesive and frosted microscope slides, coverslips, slide storage trays/mailers, cassette storage boxes, biopsy pads, histology wax plus, microtome blades, and marking dyes and sets, as well as MiPlatform, a smartphone adapter. It also provides sampling products, comprising septa, caps, liners, crimping tools, well plates and sealing mats, and micro sampling tools, as well as automation systems for the analysis of biological, food, and environmental samples. In addition, the company offers automation workflow solutions, micro sampling devices, testing, and data analysis services. Trajan Group Holdings Limited was incorporated in 2011 and is headquartered in Ringwood, Australia.

Financial highlights

Market Capitalization$229.7132 million
P/E Ratio122.92
P/E Growth Ratio
Book Value0.852
Dividend Per Share0
Earnings Per Share0.01
EBITDA15,308
Profit Margin0.0117
Operating Margin TTM0.0582
Return on Assets TTM0.0267
Return on Equity TTM0.0154
Revenue TTM162,154

Income statement highlights

All numbers are in thousands

Date Total Revenue Cost of Revenue Gross Profit Total Operating Expenses
2017-06-30 54,293 30,025 24,268
2018-06-30 57,193 32,976 24,217
2019-06-30 67,766 42,588 25,178
2020-06-30 71,852 47,500 24,352
2021-06-30 76,568 48,084 28,484 28,701
2022-06-30 107,574 64,943 42,631 37,009
2023-06-30 162,154 95,065 67,089

Balance sheet highlights

All numbers are in thousands

Date Cash Total Assets Total Liabilities Short Term Debt Long Term Debt Common Stock
2017-06-30 2,337 30,669 19,275 0 2,790 3
2018-06-30 3,546 32,545 18,918 0 48 3
2019-06-30 961 40,995 24,975 0 4,500 3
2020-06-30 846 44,195 26,455 0 4,286 3
2021-06-30 51,717 99,380 33,298 8,428 0 48,171
2022-06-30 13,164 206,779 90,273 56,380 0 96,258
2023-06-30 11,038 229,041 99,512 38,706

Cash flow highlights

All numbers are in thousands

Date Net Income Total Cash Change in Cash Begin period cash End period cash Dividends
2017-06-30 691 2,107 250
2018-06-30 1,448 1,694 1,209 3,350
2019-06-30 2,142 2,839 436 3,350
2020-06-30 2,608 1,761 804 4,786 3,350
2021-06-30 1,880 9,860 46,931 4,786 51,717 3,350
2022-06-30 1,704 2,738 -38,553 51,717 13,164 49,215
2023-06-30 1,889 -2,366 13,164 11,038